New combo therapy aims to improve blood sugar in type 2 diabetes patients on insulin

NCT ID NCT02081599

First seen Jan 04, 2026 · Last updated May 16, 2026 · Updated 19 times

Summary

This study looked at whether adding the pill teneligliptin to insulin helps Japanese adults with type 2 diabetes control their blood sugar better. 148 participants took the combination for 16 weeks, with some continuing up to 52 weeks. The main goal was to see changes in HbA1c, a key blood sugar measure.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for TYPE 2 DIABETES MELLITUS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Investigational site

    Chuo-ku, Tokyo, Japan

Conditions

Explore the condition pages connected to this study.